How can REXULTI® help your patients with schizophrenia?
In this short video, Professor Gregory Mattingly summarises how REXULTI® can help improve functional outcomes for patients with schizophrenia.1* He also discusses how he utilises REXULTI® in practice and the benefits he sees in prescribing it for his patients.
*REXULTI® led to a statistically significant improvement in the Personal and Social Performance (PSP) total score compared to placebo after 24 weeks (LOCF, p<0.05) of treatment, an outcome that was sustained through to 52 weeks (LOCF, p<0.01). The PSP score is comprised of four domains: personal and social relationships, disturbing and aggressive behaviours, self-care, and socially useful activities.1,2
